Chief negotiator slammed for "complete misunderstanding" of CETA's impact on drug prices.
Negotiations over the Trans-Pacific Partnership (TPP) have long been a guarded secret, but critics say the Harper government went the extra mile to keep the latest round of talks out of the public eye...
It is Canada's challenge to ensure this country is attractive to those who are making the decisions on where to invest their dollars for the discovery and development of innovative new treatments.
So while critics try to dismiss stronger IP as nothing more than a technique to pad the bottom line of a faceless corporation, for millions of Canadians it could be a matter of life and breath.
Should the government be allowed to force pharmaceutical companies to continue manufacturing drugs that are no longer profitable, if these drugs are in the public best interest? I'm really struggling with this one.
OTTAWA - Canada is pushing back against a campaign by activists trying to block what they say are onerous intellectual property rules that would raise the price of pharmaceuticals in poor countries.Th...
The practice of Canadian municipalities “buying locally” will disappear with the signing of a Canada-EU free trade deal, and provincial development programs could go with them, according to a leaked E...
The current rush to approve medicines while manufacturers' "patent clocks" are ticking means that some medicines make it to market that later must be recalled because of harms they cause to patients -- harms that could be detected with more thorough pre-market evaluation.
OTTAWA - As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that cou...
OTTAWA — As trade talks with Europe enter the final stretch, Canada's patent drug industry is making a final push to sell their brand of medicine to Canadians. This week, Canada's Research-Based Pharm...
The cost of prescription medicines used by millions of people every day is about to plummet.The next 14 months will bring generic versions of seven of the world's 20 bestselling drugs, including the top two: cholesterol fighter Lipitor and blood thinner Plavix.